NPSR1 and cancer: Thus, galanin receptors may be a useful therapeutic target in neuroblastoma; in human cancers involving neuropeptide receptors system, novel molecules have been defined to selectively induce/inhibit one of the G-protein signalling (Heasley, 2001).